71 studies found for:    "progressive familial intrahepatic cholestasis" OR "Cholestasis, Intrahepatic"
Show Display Options
Rank Status Study
1 Recruiting Open Label Study to Evaluate Efficacy and Long Term Safety of LUM001 in the Treatment of Cholestatic Liver Disease in Patients With Progressive Familial Intrahepatic Cholestasis
Condition: Progressive Familial Intrahepatic Cholestasis (PFIC)
Intervention: Drug: LUM001
2 Completed Validation of the Itch Reported Outcome (ItchRO) Diaries in Pediatric Cholestatic Liver Disease
Conditions: Alagille Syndrome;   Progressive Familial Intrahepatic Cholestasis
Intervention:
3 Completed Induction of Labor in Intrahepatic Cholestasis of Pregnancy
Condition: Intrahepatic Cholestasis
Intervention:
4 Completed Ursodeoxycholic Acid in the Treatment of Intrahepatic Cholestasis of Pregnancy
Conditions: Intrahepatic Cholestasis;   Pregnancy
Interventions: Drug: ursodeoxycholic acid;   Drug: Placebo
5 Withdrawn The Use of Fish Oil Supplementation in Treatment of Intrahepatic Cholestasis of Pregnancy
Condition: Intrahepatic Cholestasis of Pregnancy
Intervention: Dietary Supplement: Fish Oil Supplement Group
6 Recruiting Il-17 Levels in Intrahepatic Cholestasis of Pregnancy
Condition: Intrahepatic Cholestasis of Pregnancy
Intervention:
7 Completed ABCB4 Gene Mutations in Intrahepatic Cholestasis of Pregnancy and Controls
Condition: Intrahepatic Cholestasis of Pregnancy
Intervention:
8 Active, not recruiting Study With Heptral in Subjects With Liver Disease Due to Alcohol Consumption
Condition: Intrahepatic Cholestasis Associated With Alcoholic Liver Disease
Interventions: Drug: Ademetionine IV+tablet;   Drug: Ademetionine tablet
9 Recruiting A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of Repeat Doses of GSK2330672 Administration in Subjects With Primary Biliary Cirrhosis (PBC) and Symptoms of Pruritus
Condition: Cholestasis, Intrahepatic
Interventions: Drug: GSK2330672;   Drug: Placebo;   Drug: Ursodeoxycholic acid
10 Recruiting P-wave Duration and Dispersion in Intrahepatic Cholestasis of Pregnancy
Conditions: Intrahepatic Cholestasis of Pregnancy;   Arrhythmia
Intervention:
11 Unknown  Ursodeoxycholic Acid And Cholestasis Of Pregnancy
Condition: Intrahepatic Cholestasis of Pregnancy
Interventions: Drug: Ursodeoxycholic Acid;   Drug: Placebo
12 No longer available Buphenyl Therapy for Byler's Disease
Condition: Byler Disease
Intervention: Drug: Buphenyl
13 No longer available Transition From Buphenyl to RAVICTI for the Therapy of Byler Disease
Condition: Byler Disease
Intervention: Drug: Glycerol phenylbutyrate
14 Temporarily not available Expanded Access Protocol for an Intermediate Size Population - RAVICTI for Byler Disease
Condition: Byler Disease
Intervention: Drug: RAVICTI
15 Recruiting Evaluating the Genetic Causes and Progression of Cholestatic Liver Diseases (LOGIC)
Conditions: Liver Diseases;   Alagille Syndrome;   Alpha 1-Antitrypsin Deficiency
Intervention:
16 Terminated Second-line Therapy of Unresectable Cholangiocarcinoma by RADIOEMBOLIZATION
Condition: Cholestasis, Progressive Familial Intrahepatic 3
Intervention: Device: Yttrium microsphere injection
17 Unknown  Sulfation of Bile Acids as a Biomarker for Hepatobiliary Diseases
Condition: Hepatobiliary Diseases
Intervention:
18 Recruiting Ursodeoxycholic Acid Plus Budesonide Versus Ursodeoxycholic Acid Alone in Primary Biliary Cirrhosis (PBC)
Condition: Primary Biliary Cirrhosis
Interventions: Drug: budesonide;   Drug: budesonide placebo
19 Active, not recruiting Phase 2 Study on Effects of Obeticholic Acid (OCA) on Lipoprotein Metabolism in Subjects With Primary Biliary Cirrhosis
Condition: Primary Biliary Cirrhosis
Intervention: Drug: obeticholic acid (OCA)
20 Completed Modafinil in the Treatment of Fatigue in Patients With Primary Biliary Cirrhosis (PBC)
Conditions: Fatigue;   Primary Biliary Cirrhosis
Intervention: Drug: Modafinil

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years